RVL Pharmaceuticals Overview
- Year Founded
-
2000
- Status
-
Private
- Employees
-
127
- Latest Deal Type
-
Bankr. Admin/Reorg
- Financing Rounds
-
10
- Investments
-
2
RVL Pharmaceuticals General Information
Description
RVL Pharmaceuticals PLC is a pharmaceutical company focused on the commercialization and development of products that target markets with underserved patient populations in the ocular medicine and medical aesthetics therapeutic areas. Its revenues consist of product sales, royalty revenues and licensing revenue.
Contact Information
Website
www.rvlpharma.comCorporate Office
- 400 Crossing Boulevard
- Bridgewater, NJ 08807
- United States
Corporate Office
- 400 Crossing Boulevard
- Bridgewater, NJ 08807
- United States
RVL Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
RVL Pharmaceuticals Comparisons
Industry
Financing
Details
RVL Pharmaceuticals Competitors (24)
One of RVL Pharmaceuticals’s 24 competitors is Dalton Pharma Services, a Corporate Backed or Acquired company based in Toronto, Canada.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Dalton Pharma Services | Corporate Backed or Acquired | Toronto, Canada | ||||
| Tris Pharma | Private Debt Financed | Monmouth Junction, NJ | ||||
| Amneal Pharmaceuticals | Formerly PE-Backed | Bridgewater, NJ | ||||
| AbbVie | Corporation | North Chicago, IL | ||||
| Merck & Co. | Corporation | Rahway, NJ |
RVL Pharmaceuticals Patents
RVL Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20210353558-A1 | Composition and method for treating neurological disease | Active | 15-Feb-2018 | ||
| US-20210353559-A1 | Composition and method for treating neurological disease | Active | 15-Feb-2018 | ||
| US-10213402-B2 | Controlled release dosage form | Active | 20-Feb-2015 | ||
| US-10213403-B2 | Controlled release dosage form | Active | 20-Feb-2015 | ||
| US-10213404-B2 | Controlled release dosage form | Active | 20-Feb-2015 | A61K31/197 |
RVL Pharmaceuticals Signals
RVL Pharmaceuticals Acquisitions (2)
RVL Pharmaceuticals’s most recent deal was a Merger/Acquisition with RevitaLid for . The deal was made on 01-Jan-2017.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| RevitaLid | 01-Jan-2017 | Merger/Acquisition | Other Pharmaceuticals and Biotechnology | ||
| Vertical Pharmaceuticals | 01-Dec-2013 | Merger/Acquisition | Pharmaceuticals |
RVL Pharmaceuticals Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Vertical Pharmaceuticals | Alpharetta, GA | 2003 |
RVL Pharmaceuticals FAQs
-
When was RVL Pharmaceuticals founded?
RVL Pharmaceuticals was founded in 2000.
-
Where is RVL Pharmaceuticals headquartered?
RVL Pharmaceuticals is headquartered in Bridgewater, NJ.
-
What is the size of RVL Pharmaceuticals?
RVL Pharmaceuticals has 127 total employees.
-
What industry is RVL Pharmaceuticals in?
RVL Pharmaceuticals’s primary industry is Drug Discovery.
-
Is RVL Pharmaceuticals a private or public company?
RVL Pharmaceuticals is a Private company.
-
What is RVL Pharmaceuticals’s current revenue?
The current revenue for RVL Pharmaceuticals is .
-
How much funding has RVL Pharmaceuticals raised over time?
RVL Pharmaceuticals has raised $304M.
-
Who are RVL Pharmaceuticals’s competitors?
Dalton Pharma Services, Tris Pharma, Amneal Pharmaceuticals, AbbVie, and Merck & Co. are some of the 24 competitors of RVL Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process